Bechs Biotech Holding ApS: Financial statements 2025
CVR: 43342452
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Bechs Biotech Holding ApS (CVR 43342452) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,300 and a net result of DKK -1,300 compared with DKK -1,188 the year before. Equity in the 2025 report amounted to DKK 49,700. The solvency ratio was 100%.
- Gross Profit
- DKK -1,300
- Profit/Loss
- DKK -1,300
- Equity
- DKK 49,700
- Total Assets
- DKK 49,700
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -1K | -1K | 50K | 0 |
| 2024 | - | -1K | -1K | 44K | 0 |
| 2023 | - | -1K | -1K | 45K | - |
Official annual report
How creditworthy is Bechs Biotech Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Bechs Biotech Holding ApS has published its annual report for 2024. Gross profit came to DKK -1,188, and the net result was DKK -1,188.
About Bechs Biotech Holding ApS
Bechs Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejner Bech Jensen. The company is owned by Signe Bech Bruntse, Ejner Bech Jensen and Anders Bech Bruntse. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,300 and a net result of DKK -1,300 compared with DKK -1,188 the year before. Equity in the 2025 report amounted to DKK 49,700.